The interferon (IFN)-inducible proteins mediate activities of the interferons including the cell growth-regulatory activity. We have shown that p202, an IFN-inducible 52 kDa primarily nuclear phosphoprotein whose expression in transfected cells inhibits cell proliferation, interacts with the retinoblastoma tumor suppressor protein (pRb) and the transcription factor E2F (E2F-1/ DP-1) in vitro and in vivo. p202 was shown to inhibit E2F-1/DP-1-stimulated transcription of a reporter gene and of endogenous genes. Here we report that expression of p202 inhibited E2F-4/DP-1-stimulated transcription of a reporter gene in transfected cells. Furthermore, this inhibition was associated with the inhibition of the sequence-speci®c DNA-binding of E2F-4 both in complex with the pocket proteins p107 or p130 and in its`free' form in vitro. p202 bound to p107 and p130 in vitro and in vivo and also associated with E2F-4, supporting the notion that complexes containing p107/E2F-4 or p130/ E2F-4 and p202 exist in vivo. Moreover, cotransfection of E2F-4-encoding plasmid in AKR-2B cells overcame p202-mediated inhibition of cell growth, raising the possibility that p202 contributes to cell growth inhibition by the interferons, at least in part, by modulating E2F-4-mediated transcription.
Introduction
Many of the antimicrobial, immunomodulatory and cell growth-inhibitory activities of the interferons (IFNs) are mediated by IFN-inducible proteins (DeMaeyer and DeMaeyer, 1988; Sen and Lengyel, 1992; Gutterman, 1994; Lengyel et al., 1995) . p202 is a murine, 52 kDa, primarily nuclear phosphoprotein whose level is increased in cultured cells 15 ± 20-fold in response to treatment with IFN (Choubey and Lengyel, 1993) . In vitro p202 binds to double-and single-stranded DNA nonspeci®cally . Constitutive overexpression of p202 in transfected AKR-2B and L929 cells is growth-inhibitory Lengyel, 1993, 1995; Min et al., 1996) . Moreover, in NIH3T3 cells constitutive overexpression of p202 was found to delay exit of these cells from G 0 /G 1 phase following serum starvation (Lembo et al., 1995) .
Consistent with its growth-regulatory actions, p202 was shown to bind to pRb and the transcription factor E2F (E2F-1/DP-1) in vitro and in vivo . Binding of p202 to E2F (E2F-1/DP-1) was correlated with inhibition of the sequence-speci®c DNA-binding of E2F in extracts prepared from cells transfected with a p202 encoding plasmid or treated with IFN . Moreover, expression of p202 in transfected cells inhibitied the transcriptional activity of endogenous E2F and transfected E2F-1/DP-1 as measured by the inhibition of transcription of a reporter gene (CAT) and of endogenous S phase genes (e.g. PCNA, b-myb and DHFR) . This inhibition of E2F activity by p202 did not depend on fully functional pRb. In addition to that of E2F, the transcriptional activity of the NF-kB p50 and p65, AP-1 c-Fos and c-Jun, and p53 is also modulated by p202 (Min et al., 1996; Datta et al., 1996) .
Members of the E2F family of transcription factors regulate genes whose products are essential for progression through the cell cycle. The family includes the transcription factors E2F-1, E2F-2, E2F-3, E2F-4 and E2F-5 (Ivey-Hoyle et al., 1993; La Thangue, 1994; Lees et al., 1993; Beijersbergen et al., 1994; Ginsberg et al., 1994) . Comparison of the sequences within the members of the E2F family indicates that E2F-1, E2F-2, and E2F-3 belong to one subfamily and E2F-4 and E2F-5 to the other (Sardet et al., 1995) .
The E2F proteins form heterodimers with the related DP family proteins thereby greatly enhancing their DNA-binding and transactivating activity Bandara et al., 1993; Krek et al., 1993; Ormondroyd et al., 1995) . E2F recognition sites have been found in the promoters of various growthresponsive and growth-promoting cellular genes (e.g. dihydrofolate reductase (DHFR), cdc2, b-myb, and cmyc) and were shown to contribute to the transcriptional regulation of these genes (Blake and Azizkhan, 1989; Dalton, 1992; Thalmeier et al., 1989; Adams and Kaelin, 1995; DeGregori et al., 1995) .
Overexpression of E2F-4 together with an activated ras oncogene was shown to cause oncogenic transformation of primary rodent ®broblasts (Beijersbergen et al., 1994) . Moreover, other E2F and DP family members have also been reported to have protooncogenic properties (Johnson et al., 1994a; Singh et al., 1994; Jooss et al., 1995; Xu et al., 1995) . The recent studies reveal that in some settings the E2F-1 gene may also function as a tumor suppressor gene (Weinberg, 1996) .
The activity of the E2F proteins is regulated, in part, by binding to the pRb, p107, and p130 pocket proteins (Beijersbergen et al., 1994; Ginsberg et al., 1994; Smith and Nevins, 1995; Cobrinik et al., 1993; Dynlacht et al., 1994) . Binding of pRb to E2F factors does not inhibit DNA-binding of these factors: pRb was shown to repress E2F-mediated transcription by forming a complex with E2F speci®cally bound to DNA (Weintraub et al., 1992; Johnson et al., 1994b; Sellers et al., 1995) . However, pRb was reported to be part of an inhibitory complex, E2F-I, that blocked the DNAbinding activity of E2F in extracts from mouse L cells (Bagchi et al., 1991) . pRb, p107, and p130 appear to bind to dierent subsets of E2F and in dierent phases of the cell cycle. p107 interacts preferentially with E2F-4 in cycling cells; whereas pRb interacts with E2F-1, E2F-2, and E2F-3; and p130 interacts with E2F-4 and E2F-5 (Cobrinik, 1996) . Furthermore, p130/E2F complexes are detected in cells in G 0 , whereas the pRb/E2F and p107/E2F complexes appear later in G 1 and persist in S phase cells (Cobrinik, 1996) . The mechanisms whereby pRb and p107 induce growth arrest in G 1 also appear to dier from each other. Thus, while E1A overexpression can override both pRb and p107 eects, only pRb-induced growth-inhibition can be reversed by cyclin A, cyclin E, or E2F-1 (Zhu et al., 1993) .
The ability of p202 to inhibit E2F activity is of considerable interest because it may explain IFN's ability to arrest many cell lineages in the G 0 /G 1 phase of the cell cycle (De Maeyer and De Maeyer, 1988; Gutterman, 1994) . Since the E2F-4 transcription factor diers from the E2F-1 factor structurally and functionally and accounts for the vast majority of E2F activity both in complex with the pocket proteins and as a free molecule (Sardet et al., 1995; Vairo et al., 1995; Lukas et al., 1996; Mann and Jones, 1996) , testing of p202's ability to inhibit transcriptional activation by E2F-4 is warranted. We report herein that expression of p202 inhibited E2F-4-stimulated transcription of a reporter gene in transfected cells. This inhibition correlated with the presence of p202 in complexes with p107/E2F-4 and with p130/E2F-4 and the inhibition of the sequence-speci®c DNA-binding of E2F-4 complexes by p202 in vitro. p202 was demonstrated to bind to p107 and p130 both in vitro and in vivo. Our results are consistent with the possibility that binding of p202 with the pocket proteins contributes to the regulation of E2F activity.
Results

p202 inhibits E2F-4-stimulated transcriptional activity
To test whether p202 regulates E2F-4-stimulated transcription, we transfected human cervical carcinoma C33-A cells with an E2F 4 CAT reporter plasmid in which chloramphenicol acetyl transferase (CAT) expression was driven by four E2F-speci®c enhancers and tested the eect of the transfection of various plasmids on resultant CAT activity. In accord with earlier observations (Beijersbergen et al., 1994; Vairo et al., 1995) , the transfection of plasmids encoding E2F-4 and DP-1 reproducibly increased CAT activity about ninefold, and cotransfection of a plasmid encoding p107 resulted in inhibition of CAT activity in a concentration-dependent manner (Figure 1 ). Furthermore, transfection of a p202-speci®c plasmic consistently inhibited CAT activity in a concentrationdependent manner in cells transfected with both E2F-4-and DP-1-speci®c plasmids. As observed earlier Datta et al., 1996) , p202 reproducibly did not inhibit transcription of a reporter gene (b-gal), an internal control for transfection eciency, driven by the SV40 enhancer. These observations along with the earlier observations in which p202 did not inhibit the activities of SP1 and OCT1 enhancers (Min et al., 1996) , suggest that p202 does not inhibit transcription nonspeci®cally. Thus, experiments reported here indicate that in transient assays p202 can inhibit E2F-4-stimulated transcription in a concentration-dependent manner.
p202 inhibits the sequence-speci®c DNA-binding of E2F-4 complexes To test the eect of p202 expression on the sequencespeci®c DNA-binding of E2F-4, we analysed the DNAbinding species of E2F by electrophoretic mobility shift assays (EMSA) in extracts prepared from growing murine AKR-2B cells. Consistent with our earlier results , we detected one E2F-speci®c band (Figure 2a , lane 1) in extracts prepared from cells transfected with the plasmid pCMV (control cells). Addition of deoxycholate (DOC), which is known to dissociate proteins from the E2F complexes (Bagchi et al., 1991) , gave rise to a new E2F-speci®c band (`free E2F', Figure 2a , lane 2). This result indicated that extracts from growing AKR-2B cells do not normally contain detectable amounts of free E2F. Incubation of extracts with anti-pRb did not result in a supershift (lane 3), indicating that pRb/E2F complexes were not detectable. This observation is consistent with our earlier observation that AKR-2B murine ®broblasts contain very low levels of pRb . However, addition of anti-p107-speci®c (lane 4) or anti-p130-speci®c (lane 5) antibodies resulted in a supershift of signi®cant amounts of E2F complexes, indicating that these extracts contained p107/E2F and p130/E2F complexes. Since p107 is known to associate with E2F-4 preferentially in vivo (Beijerbergen et al., 1994) , we immunoprecipitated p107 from extracts prepared from cycling AKR-2B cells using monoclonal anti-p107 antibodies and examined the associated E2F activity by EMSA following DOC release. As shown in Figure  2b , anti-p107 antibodies immunoprecipitated E2F activity (lane 3), which was partially supershifted by anti-E2F-4 antibodies (lane 4). These results indicate that extracts from growing AKR-2B cells contained detectable p107/E2F-4 complexes.
We next tested whether consitutive overexpression of p202 in three stable AKR-2B cell lines (CO-1, CO-3, and CO-6) inhibited the sequence-speci®c DNAbinding of E2F complexes. As reported earlier , cells from these stable lines grew much slower than control AKR-2B cells (transfected with pCMV vector) and appeared larger and¯atter. Extracts from these cells expressing elevated levels of p202 exhibited much lower sequence-speci®c DNA-binding of E2F than extracts from control cells ( Figure 2c , compare lanes 3, 4 and 5 with lane 1). Thus even a modest 2 ± 3-fold overexpression of p202 in AKR-2B cells is sucient to impair the speci®c DNA-binding activity of most of the p107/E2F-4 and p130/E2F-4 complexes present in AKR-2B extracts. It should be noted that overexpression of p202 did not decrease levels of E2F-4 protein in these stable cell lines (also see Figure 3a ).
Since in transient assays transfection of a p202-encoding plasmid in C33-A cells inhibited E2F-4-stimulated transcription of a reporter gene, we examined whether transfection of a p202-encoding plasmid in C33-A cells aects the DNA-binding of E2F. We transfected pCMV-202 plasmid or, as a control, the pCMV vector into growing C33-A cells. The extracts from control cells revealed two E2F-speci®c bands: the free E2F band and in complex with the pocket proteins ( Figure 2d , lane 4). The expression of p202 in the transfected cells inhibited the DNAbinding activity of E2F in the extracts (lane 5). The extent of inhibition in two experiments varied from 70 ± 80%. Furthermore, the addition of an extract from pCMV-202 transfected cells to an extract from control cells (transfected with pCMV) (in a 1 : 1 ratio) resulted in a strong inhibition of DNA-binding of E2F (compare lane 4 and lane 6). This revealed that p202 in the extracts from pCMV-202 transfected cells inhibited DNA-binding of E2F in the extracts from control cells (i.e. in trans). As reported earlier , incubation of extracts from control cells with EDTA (a chealating agent known to diminish ionic interactions between proteins) did not signi®cantly increase DNA-binding by E2F in the extracts (lane 7). It did, however, partially overcome inhibition of the DNA-binding activity of E2F in the extracts from pCMV-202 transfected cells (Figure 2d , compare lanes 5 and 8). These results revealed that transfection of a p202-encoding plasmid in C33-A cells inhibited the sequence-speci®c DNA binding of E2F both in complex with the pocket proteins and in its free form in extracts.
To assess whether the eect of p202 on DNAbinding of E2F-4 was direct, we immunoprecipitated E2F-4 activity using anti-p107 antibodies as described above and incubated the immunoprecipitates with DOC to release proteins from p107. The released E2F activity was incubated with increasing amounts of puri®ed GST protein ( Figure 2e , lanes 5, 6 and 7) or a GST-p202 (19-445) fusion protein ( Figure 2e , lanes 8, 9, and 10) before binding to the labeled E2F consensus oligonucleotide. As shown in Figure 2e , , but not GST, inhibited the sequence-speci®c DNA-binding of E2F-4 (which coprecipitated with p107) in a concentration-dependent manner. This result indicated that in vitro binding of p202 to E2F-4 could inhibit the sequence-speci®c DNA-binding of E2F-4 without a necessity for the presence of p107.
E2F-4 binds p202
To examine whether E2F-4 protein interacts with p202, we immobilized the glutathione-S-transferase-p202 (GST-p202) fusion proteins on glutathione-Sepharose beads and incubated extracts prepared from untreated or IFN-treated murine AKR-2B cells. As seen in Figure 3a , E2F-4 from either of these extracts bound to but not to GST (compare lanes 1 and 2 with lanes 3 and 4). IFN-treatment of AKR-2B cells did not aect levels of E2F-4 bound to GST-p202 (Figure 3a , compare lane 3 with 4). It should be noted that in this assay we cannot rule out the possibility that binding of cellular E2F-4 to GST-p202 is through an adaptor protein (i.e. indirect). Furthermore, binding of E2F-4 to p202 in these assays was independent of contaminating DNA in cellular extracts because addition of ethidium bromide (Lai and Herr, 1992) in the assays did not aect interactions between E2F-4 and p202 (not shown). Thus these results indicated that E2F-4 binds to p202 in vitro.
The association of E2F-4 with p202 in vivo was explored using extracts from AKR-2B cells that had been treated with IFN to increase the level of p202. Proteins immunoprecipitated with anti-E2F-4 antibodies were analysed by SDS ± PAGE and Western blotting with immunoanity-puri®ed anti-p202 antibodies conjugated to horseradish peroxidase. As a control, extracts were also immunoprecipitated with an unrelated antibody (anti-MyoD). As seen in Figure 3b , p202 coimmunoprecipitated with E2F-4 but was not present in anti-MyoD immunoprecipitates. It should be noted that anti-E2F-4 antibodies did not cross-react with p202 and thus immunoprecipitated p202 only as a consequence of its association with E2F-4 (not shown).
Since overexpression of p202 in stable AKR-2B cell lines inhibited the sequence-speci®c DNA-binding of p107/E2F-4 complexes, we explored whether anti-E2F-4 immunoprecipitates (as described in Figure 3b ) also contained p107. For this purpose, we analysed proteins immunoprecipitated by anti-E2F-4 antibodies for the presence of p107 by Western blotting. As indicated in Figure 3c , both p107 and p202 coimmunoprecipitated with E2F-4, indicating that IFN-treated AKR-2B cells may contain speci®c p107/E2F-4/p202 complexes.
Coexpression of E2F-4 can overcome growth inhibition by p202
Since cotransfection of a p202-encoding plasmid in cultured cells inhibited E2F-4-mediated transcription and this correlated with the inhibition of the sequence- speci®c DNA-binding of E2F-4 complexes in EMSA, we sought to examine whether coexpression of E2F-4 would overcome p202-mediated inhibition of cell proliferation. When AKR-2B cells were contransfected with pCMV-E2F-4, which contains the E2F-4 cDNA, under control of a strong CMV promoter, linked to the neo-R gene and selected with G418, we reproducibly obtained signi®cantly more G418-resistant colonies than from cells transfected with a p202-encoding plasmid (pCMV-202) alone or cotransfected with pCMV (Table 1) . Consistent with our earlier results Lengyel, 1993, 1995) , transfection of a p202 expression plasmid in AKR-2B cells in two independent experiments resulted in very few G418-resistant colonies (1.25 ± 2%) as compared to vector alone (Table 1) . Thus, these results are consistent with the notion that p202 inhibits cell growth, at least in part, by sequestering E2F factors and overexpression of E2F-4 can overcome p202-mediated inhibition of cell growth.
Interaction of the pocket proteins p107 and p130 with p202
Since constitutive overexpression of p202 in cells of stable AKR-2B cell lines inhibited the sequence-speci®c DNA-binding of E2F complexes comprising the pocket protein p107 or p130, we tested whether p202 would interact with p107 or p130. For this purpose, we immobilized the glutathione-S-transferase-p107 (252-936) fusion protein on glutathione-Sepharose beads and used the beads as anity reagents for 35 S-labeled p202 protein translated in vitro. The GST-p107 (252-936) beads selectively retained p202 (Figure 4a, lane 3) , as did the positive control GST-E2F-1 (lane 4), whereas the GST-Sepharose beads did not (lane 2). Furthermore, immobilized, essentially full-size p202 (GST-p202 (19-445)) ) bound 35 S-labeled p107 and p130 (Figure 4b , lanes 3 and 7, respectively), as did GST-E1A (lanes 4 and 8, respectively), whereas immobilized GST did not (lanes 2 and 6, respectively).
Since p107 and p130 (Adams and Kaeline, 1995) and p202 (Choubey and Lengyel, 1993) can be phosphorylated in vivo, which could aect their ability to interact, we tested whether p107 or p130 from extracts of growing AKR-2B cells would bind to p202. We incubated extracts from murine AKR-2B cells with immobilized p202 (or GST) and analysed eluted proteins by Western blotting using anti-p107 ( Figure  4c ) or anti-p130 (Figure 4d ). Cellular p107 was selectively retained on immobilized p202 but not on GST. Similarly, cellular p130 was selectively retained on immobilized p202 or GST-E1A (used as a positive control) but not on GST.
In a`far-Western' assay, p107 and p130 selectively bound to anity-puri®ed (Figure  4e , lane 6 and lane 9, respectively), but not to GST (lanes 5 and 8, respectively) or to a series of protein size markers (lanes 4 and 7, respectively). This experiment also indicated that p107 and p130 can directly bind to p202.
To identify domains in p202 involved in binding to p107, we generated a series of GST-p202 deletion mutants and incubated them with cell extracts prepared from growing AKR-2B cells. p107 from cell extracts did not bind to the GST-p202 (295-445) segment (Figure 4f , lane 6), but did bind to various other p202 segments (lanes 3, 4, and 5), the shortest of which was GST-202 (255-293) (lane 5).
The in vivo association between p107 and p202 was explored by performing immunoprecipitations with monoclonal anti-p107 antibodies on 35 S-methioninelabeled extracts prepared from AKR-2B cells exposed to IFN or left unexposed. As seen in Figure 4g We tested the in vivo association between p130 and p202 by immunoprecipitating proteins using anti-p130 antibodies from extracts prepared from untreated or IFN-treated AKR-2B cells followed by Western blotting using immunoanity-puri®ed anti-p202 antibodies coupled to horseradish peroxidase. As shown in Figure 4h , an interferon-inducible protein that comigrated with p202 in total cell extracts prepared from 
Discussion
The treatment of IFN-responsive hematopoietic cells with IFN-a is known to arrest these cells in the G 0 /G 1 phase of the cell cycle and to inhibit DNA-binding activity of the E2F transcription factor (DeMaeyer and DeMaeyer, 1988; Gutterman, 1994; Melamed et al., 1993) . Since overexpression of p202 inhibited the growth of murine AKR-2B and L929 cells Lengyel, 1993, 1995; Min et al., 1996) and delayed the exit of NIH3T3 cells from G 0 /G 1 phase following serum starvation (Lembo et al., 1995) , we tested whether p202 aects E2F(E2F-1/DP-1)-mediated transcription. Our studies revealed that expression of p202 in transfected cells inhibits E2F (E2F-1/DP-1)-stimulated transcription and this inhibition correlates with the inhibition of the sequencespeci®c DNA-binding of E2F complexes in vitro . Furthermore, p202 binds to E2F-1 in vitro and in vivo.
Since E2F-4 was suggested to contribute to the regulation of early G 1 events including the G 0 /G 1 transition (Sardet et al., 1995) , we investigated whether overexpression of p202 might inhibit E2F-4-mediated transcription. The results presented in this study reveal that p202, like the p107 pocket protein, can inhibit E2F-4-stimulated transcription in transfected cells and thereby shed light on a mechanism that is likely to contribute to growth regulation by p202 and the IFNs that induce p202 expression.
In transient transfection assays using a p202 expression plasmid, the transcriptional activity of the E2F-4 transcription factor was inhibited. Since p202 bound to E2F-1 in vitro in a segment (amino acids 88 ± 241) comprising the DNA-binding domain of E2F-1 , a domain conserved among the E2F family members (Jordan et al., 1994; Sardet et al., 1995) , and this binding correlated with the inhibition of AKR-2B cells were transfected with the indicated expression plasmids and cells were selected for G148-resistance as described in Materials and methods.
a G418-resistant colonies as a percentage of the number of colonies obtained using the vector pCMV p202 inhibits E2F-4-mediated transcription D Choubey and JU Gutterman the sequence-speci®c DNA-binding of E2F complexes in extracts, we predicted that p202 binding would aect DNA-binding of other E2F family members. This prediction turned out to be accurate: (i) constitutive overexpression of p202 in three stable AKR-2B cell lines inhibited the sequence-speci®c DNA-binding of E2F-4 complexes comprising the pocket protein p107 or p130; (ii) incubation of puri®ed GST-p202(19-445), but not GST, with E2F-4 recovered from immunoprecipitates isolated using anti-p107 also inhibited the sequence-speci®c DNA-binding of E2F-4 in a concentration-dependent manner. Several observations reported in this study are consistent with the notion that p202 can simultaneously interact with p107 or p130 protein and E2F-4: (i) p202 associated with the cellular E2F-4 in vitro and in vivo; (ii) p202 and p107 coimmunoprecipitated with E2F-4 from the cell extracts prepared from IFNtreated cells, indicating an association in vivo; (iii) constitutive overexpression of p202 inhibited the sequence-speci®c DNA-binding of E2F-4 complexes containing p107/E2F-4 or p130/E2F-4; and (iv) p202 bound to p107 and p130 in vitro and in vivo. Our observation that p202 can simultaneously bind to E2F-4 transcription factor and a pocket protein is consistent with our earlier ®nding that p202 and pRb bind to distinct and nonoverlapping domains of E2F-1 , thus making it conceivable that a complex including all three of these proteins (and possibly also a DP protein) exists in vivo.
It remains to be seen whether p107 and p130, like pRb, have two nonoverlapping domains to bind p202 . Furthermore, it remains to be established whether phosphorylation of E2F-4, p107 and p130 by cyclin-dependent kinases aects their interactions with p202.
We have found that overexpression of p202 could inhibit growth of SAOS-2 cells, a human osteosarcoma cell line with defective pRb (Shew et al., 1990) , in colony formation assays, indicating that growth inhibition by p202 was not dependent on fully functional pRb (Choubey, unpublished data) . It remains to be established whether growth inhibition by p202 is dependent on functional p107 or p130.
Although E2F-1 and E2F-4 share several homologous domains, they dier from each other structurally and functionally. Thus: (i) E2F-4 is more closely related to E2F-5 (78% similarity at the nucleotide level) than E2F-1 (57% similarity at the nucleotide level) (Sardet et al., 1995) ; (ii) E2F-1, -2, and -3 encode a cyclin/cdk binding sites that is not apparent in E2F-4 or E2F-5 (Sardet et al., 1995) ; (iii) in primary human T cells the major G 0 E2F activity is E2F-4 not E2F-1 (Vairo et al., 1995) ; (iv) in synchromized human keratinocytes E2F-4 mRNA expression was reported to be maximal in mid-G 1 phase, before E2F-1 expression became detectable, suggesting that E2F-4 may contribute to the regulation of early G 1 events including the G 0 /G 1 transition (Sardet et al., 1995) ; (v) E2F-1 can promote S-phase entry by itself, whereas E2F-4 cannot (Lukas et al., 1996) ; and (vi) E2F-1, but not E2F-4, can overcome p16-induced G 1 cell-cycle arrest (Mann and Jones, 1996; Lukas et al., 1996) . Since the regulatory pocket proteins bind to E2F-1 and E2F-4 at de®ned but dierent stages of the cell cycle, this speci®city is likely to play an important role in determining both the timing and length of activation of the individual E2F/DP heterodimers. It has also been suggested that dierences in either the intrinsic properties of the E2F/DP heterodimers and/or the modulating eects of the associated regulatory proteins might cause the pRb-speci®c (E2F-1, E2F-2, and E2F-3) and p107-/p130-speci®c E2Fs (E2F-4 and E2F-5) to activate dierent classes of responsive genes (Slansky and Farnham, 1996; Dagnino et al., 1995) . In fact p107/E2F complexes, but not pRb/E2F, were reported to contribute to b-myb transcriptional regulation, thus providing the ®rst example of speci®c role for p107 in the regulation of the cell cycle (Lam et al., 1994 .
The results presented herein indicate that the IFNinducible p202 protein, in addition to inhibiting E2F-1-mediated transcription, can inhibit E2F-4-mediated transcription, raising the possibility that transcriptional activity of other members of the E2F family is also modulated by p202. Our observations that: (i) p202 expression inhibited E2F-4-stimulated transcription of a reporter gene (this study) and of an endogenous gene (b-myb) , whose transcription was reported to be regulated by E2F-4/p107 (Lam et al., 1994 and (ii) cotransfection of E2F-4 expression plasmid in AKR-2B cells overcame p202-mediated growth inhibition of cells in colony formation assays make it conceivable that p202 inhibits cell growth, at least in part, by inhibiting E2F activity.
Though when overexpressed in transfected cells both p202 and p107 inhibit transactivation by E2F-4, p202 impairs the speci®c binding of E2F-4 to DNA, whereas p107 does not. Since p107, like pRb, has been shown to repress transcription when brought directly to promoter (Bremner et al., 1995; Zwicker and Muller, 1997) , our observations reported here make it conceivable that p202 expression also aects E2F-4-dependent repression of genes. Further work involving identi®cation of genes whose transcription is repressed by p107/E2F-4 complexes will be required to address this issue. Moreover, the inhibition of the sequencespeci®c DNA-binding of E2F-4 transcription factor by p202 provides one further means by which E2F-4 activity may be regulated during cell cycle.
Materials and methods
Cell lines, growth conditions and treatment with IFN
Murine AKR-2B cells and human cervical carcinoma C-33A cells (from American Type Culture Collection) were grown in Dulbeco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum (Choubey and Lengyel, 1992) . When indicated, the cells were treated with recombinant human IFN a 2 /a 1 1 ± 83 (1000 U/ml) for the time indicated.
Plasmids and transfections
The plasmids constructed for expression of labeled p202 (in reticulocyte lysates) and GST-202 proteins in E. coli have been described . Human p107 protein was transcribed and translated in vitro from the plasmid pBluescript SK(7) containing the p107 cDNA (Ewen et al., 1991) (a generous gift from Drs DM Livingston and M Ewen). GST-p107 (252-936) was p202 inhibits E2F-4-mediated transcription D Choubey and JU Gutterman provided by Drs DM Livingston and M Ewen. Human p130 protein was transcribed and translated in vitro from the plasmid pBS-SK containing the p130 cDNA (a generous gift from Dr P Whyte). The plasmids pCMV and pCMV-202 have been described . The GST-E2F-1 (2-437) plasmid was constructed by ligating a StyI ± BamHI DNA fragment from pCMV-E2F-1 (after blunt ending) into the SmaI site of the pGEX-2T vector (Pharmacia). GST-E1A was constructed by ligating an E1A cDNA fragment with pGEX vector. pCMV-DP-1 and E2F 4 CAT plasmids were kindly provided by K Helin and E Harlow (Helin et al., 1992 . pCMV-E2F-4 was constructed from a plasmid kindly provided by Dr R Weinberg (Sardet et al., 1995) . Transfections and reporter assays C33-A cells grown on 100 mm culture dishes were transfected using the calcium phosphate precipitation method (Sambrook et al., 1989) with 2 mg of E2F 4 CAT reporter plasmid (CAT expression driven by four E2F-speci®c sequences), 2 mg pSVL-b-gal (b-galactosidase expression driven by SV40 enhancer and promoter) as the internal control plasmid, and, if so indicated, with plasmids encoding E2F-4 (pCMV-E2F-4, 0.2 mg), DP-1 (pCMV-DP-1, 2 mg), p107 (pCMV-p107) or p202 in the amounts speci®ed. pBluescript SK was used to adjust the total amount of DNA transfected to 20 mg. The cultures were harvested after 42 h, and the transfected cells were resuspended in 100 ml of 0.1 M Tris-HCl (pH 8.0). The cells were freeze-thawed three times and microfuged at 48C for 15 min. Supernatants were assayed for bgalactosidase activity (Stratagene kit) and CAT activity using the phase extraction method (Seed and Sheen, 1988) . The variation in b-galactosidase speci®c activity was less than twofold. Protein concentration was determined by the Bio-Rad protein assay kit.
For colony formation assays culture plates (diameter 100 mm) of AKR-2B cell containing *10 6 cells were transfected by calcium phosphate precipitation with 4 mg of expression plasmids. For cotransfections pCMV-202 expression plasmid DNA (2 mg) was mixed with pCMV plasmid (2 mg) or pCMV-E2F-4 plasmid DNA (2 mg). Following 24 h transfections, cells were dispersed with trypsin-EDTA and seeded in three 100 mm-diamter plates. Cells were selected in 500 mg/ml of G418 for about 2 weeks. G418-resistant colonies obtained were stained with crystal violet and those which had diameter of about 1.5 ± 2 mm were counted.
Expression of GST-fusion proteins, preparation of cell extracts and anity chromatography
For expressing GST-fusion proteins, the appropriate plasmids were introduced into E. coli BL21. The fusion proteins were anity puri®ed on glutathione-Sepharose beads as described , and their amounts were estimated by SDS ± PAGE. The beads were loaded with fusion proteins and extracts from AKR-2B cells were prepared and subjected to anity chromatography on the immobilized fusion proteins as reported earlier .
Immunoprecipitation and Western blotting
Extracts from AKR-2B cells (control or treated with IFN for the indicated times) were prepared as described . For labeling of proteins, cells were treated with IFN (1000 U/ml) overnight and cells were labeled with [
35 S]methionine (0.5 mCi/ml; Amersham) for 3.5 h as described before (Choubey and Lengyel, 1993) . The extracts were incubated with anti-p107 (clone SD9) or anti-p130 (clone C-20) (Santa Cruz Biotechnology, Inc.) at 48C for 90 min. The complexes were recovered by binding to protein A/G Sepharose at 48C for 45 min. The beads were washed and the bound proteins were either dissociated with DOC or eluted with extraction buer supplemented with 500 mM NaCl and analysed by immunoblotting with an anti-202 antiserum or anti-p202 conjugated to horseradish peroxidase as described earlier .
Transcription and translation in vitro
Transcripts for p202, p107, and p130 were generated from pBluescript-202, pBluescript SK(7)-107, and pBS SKp130, respectively, and were translated in rabbit reticulocyte lysate supplemented with [
35 S]methionine, as described (Choubey et al., 1989) .
Electrophoretic mobility shift assays (EMSA)
Preparation of extracts from control or transfected AKR-2B cells and the conditions for EMSA have been described before . For supershift assays extracts were incubated at 48C for 2 ± 3 h with the indicated antibodies followed by EMSA.
